Sunesis Pharmaceuticals
4.3 of 5 3 reviews
www.sunesis.com South San Francisco, CA 16 to 50 Employees
Suggest Edits

Be The First To
Add Photos

Unknown
Company - Public (SNSS)
Biotech & Pharmaceuticals
$5 to $10 million (USD) per year

Sunesis builds drugs in miniature first before it builds them in full scale. The biotech firm's method involves building small drug fragments and then examining their protein-binding ability and potential for development. Once a fragment shows potential, Sunesis then builds a larger therapeutic compound based upon its model. Its drug candidates target various forms of cancer. Its lead candidate SNS-595 is in clinical trials to evaluate its effect on ovarian cancer and acute myeloid leukemia. Its other candidates include SNS-314, which is being studied for its effect on... More

Working at Sunesis Pharmaceuticals

Posted by employees

Employees are “Very Satisfied”   3 ratings

4.3

50% Approve of the CEO   2 ratings

Sunesis Pharmaceuticals President, CEO, and Director Dan Swisher Jr.

Dan Swisher Jr.

President, CEO, and Director

good, respectful coworkers and management

 Former Employee in South San Francisco, CA

Pros: bright, respectful, dedicated employees and considerate management Full Review

More Sunesis Pharmaceuticals Ratings & Reviews ( 3)

Salaries in USD  United States Avg. Salary
$100k
$170k
$240k

Scientist

1 Sunesis Pharmaceuticals Salary

n/a
$97k
$104k

Vice President, Clinical Research

1 Sunesis Pharmaceuticals Salary

n/a
$275k
$301k

= Salary Range

= Anonymous Salary Range

= Avg.

More Sunesis Pharmaceuticals Salaries (2)

Sunesis Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Sunesis Pharmaceuticals? Contribute to the Community!

Financial Information

Glassdoor is your free inside look at what it's like to work at Sunesis Pharmaceuticals - including salaries, reviews, office photos, and more. All content posted anonymously by employees working at Sunesis Pharmaceuticals.